3Chen HS, Wu MS, Yen TS. Soluble interleukin-2 receptor in patients with glomerular diseases [ J ]. Postgrad Med J, 1995,71 (840) :617- 622. 被引量：1
4Cho BS, Yoon SR, Jang JY. Up-regulation of interleukin- 4 and CD23/FcepsilonRII in minimal change nephrotic syndrome [ J ]. Pediatr Nephrol, 1999,13 (3) : 199-204. 被引量：1
5Matsumoto K, Ohi H, Kanmatsuse K. Interleukin-4 cooperates with interleukin-10 to inhibit vascular permeability factor release by peripheral blood mononuclear ceils from patients with minimal-change nephrotic syndrome [ J ]. Am J Nephrol, 1999,19 ( 1 ) :21-27. 被引量：1
6Zachwieja J, Bobkowski W. Dobrowolska-Zachwieja A. Intracellular cytokines of peripheral blood lymphocytes in nephrotic syndrome [ J ]. Pediatr Nephrol,2002,17 ( 9 ) :733-740. 被引量：1
7Laflam PF, Haraguchi S, Garin EH, et al. Cytokine mRNA profile in lipoid nephrosis: evidence for increased IL-8 mRNA stability [ J ]. Nephron ,2002,91 (4) :620- 626. 被引量：1
8Daniel V, Trautmann Y, Konrad M, et al. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome[ J ]. Clin Nephrol, 1997, 47 (5) :289-297. 被引量：1
9Matsumoto K. Interleukin 10 inhibits vascular permeability factor release by peripheral blood mononuclear ceils in patients with lipoid nephrosis[ J ]. Nephron, 1997,75 (2) : 154-159. 被引量：1
10Matsumoto K, Ohi H, Kanmatsuse K. Interleukin 12 upregulates the release of vascular permeability factor by peripheral blood mononuclear cells from patients with lipoid nephrosis[ J ]. Nephron, 1998, 78(4) :403- 409. 被引量：1
